TREATMENT OF HUMAN RENAL CELL CARCINOMA BY A CONDITIONALLY REPLICATING HERPES VECTOR G207
- 1 April 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 165 (4) , 1274-1278
- https://doi.org/10.1016/s0022-5347(05)66512-3
Abstract
Conclusions These results suggest that G207 should be considered another potential therapeutic agent for renal cell carcinoma.Keywords
This publication has 15 references indexed in Scilit:
- Intravesical and Intravenous Therapy of Human Bladder Cancer by the Herpes Vector G207Human Gene Therapy, 2000
- Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trialGene Therapy, 2000
- Local and Systemic Therapy of Human Prostate Adenocarcinoma with the Conditionally Replicating Herpes Simplex Virus Vector G207Human Gene Therapy, 1999
- Selective Infection and Cytolysis of Human Head and Neck Squamous Cell Carcinoma with Sparing of Normal Mucosa by a Cytotoxic Herpes Simplex Virus Type 1 (G207)Human Gene Therapy, 1999
- Treatment of Human Breast Cancer in a Brain Metastatic Model by G207, a Replication-Competent Multimutated Herpes Simplex Virus 1Human Gene Therapy, 1998
- Bystander Effect-Mediated Therapy of Experimental Brain Tumor by Genetically Engineered Tumor CellsHuman Gene Therapy, 1998
- Selective Destruction of Gliomas in Immunocompetent Rats by Thymidine Kinase-Defective Herpes Simplex Virus Type 1JNCI Journal of the National Cancer Institute, 1994
- In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain TumorsScience, 1992
- Mapping of Herpes Simplex Virus-1 Neurovirulence to γ 1 34.5, a Gene Nonessential for Growth in CultureScience, 1990
- Cancer statistics, 1990CA: A Cancer Journal for Clinicians, 1990